BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 27322246)

  • 1. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.
    Ahadi A
    Immunogenetics; 2021 Apr; 73(2):155-161. PubMed ID: 33399935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives.
    Link A; Kupcinskas J
    World J Gastroenterol; 2018 Aug; 24(30):3313-3329. PubMed ID: 30122873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric Juice MicroRNAs as Potential Biomarkers for Screening Gastric Cancer: A Systematic Review.
    Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Mercantini P; Balducci G; Cavallini M
    Anticancer Res; 2018 Feb; 38(2):613-616. PubMed ID: 29374683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of miR-27b in the development of gastric cancer.
    Chen X; Cui Y; Xie X; Xing Y; Yuan Z; Wei Y
    Mol Med Rep; 2018 Apr; 17(4):5081-5087. PubMed ID: 29393383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
    Shekari N; Baradaran B; Shanehbandi D; Kazemi T
    Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in gastric cancer: from bench to bedside.
    Hu ML; Xiong SW; Zhu SX; Xue XX; Zhou XD
    Neoplasma; 2019 Mar; 66(2):176-186. PubMed ID: 30509106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
    Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
    Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment.
    Mirzajani E; Vahidi S; Norollahi SE; Samadani AA
    Microrna; 2022; 11(1):12-24. PubMed ID: 35319404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of gastric cancer: Current topics and future perspective.
    Matsuoka T; Yashiro M
    World J Gastroenterol; 2018 Jul; 24(26):2818-2832. PubMed ID: 30018477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miR‑34 in gastric cancer: From bench to bedside (Review).
    Xiong S; Hu M; Li C; Zhou X; Chen H
    Oncol Rep; 2019 Nov; 42(5):1635-1646. PubMed ID: 31432176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs expression profiles as diagnostic biomarkers of gastric cancer: a systematic literature review.
    Stojanovic J; Tognetto A; Tiziano DF; Leoncini E; Posteraro B; Pastorino R; Boccia S
    Biomarkers; 2019 Mar; 24(2):110-119. PubMed ID: 30387681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets.
    Wu X; Shen J; Xiao Z; Li J; Zhao Y; Zhao Q; Cho CH; Li M
    Biochem Pharmacol; 2019 May; 163():425-439. PubMed ID: 30857828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.
    Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J
    Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide analysis of multi-view data of miRNA-seq to identify miRNA biomarkers for stomach cancer.
    Pant N; Rakshit S; Paul S; Saha I
    J Biomed Inform; 2019 Sep; 97():103254. PubMed ID: 31352060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspectives on the dysregulated microRNAs in gastric cancer.
    Azarbarzin S; Safaralizadeh R; Khojasteh MB; Baghbanzadeh A; Baradaran B
    Mol Biol Rep; 2020 Sep; 47(9):7253-7264. PubMed ID: 32776162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
    Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
    Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of miRNAs in the development and clinical application of gastric cancer.
    Wu SR; Wu Q; Shi YQ
    Chin Med J (Engl); 2020 Aug; 133(15):1856-1867. PubMed ID: 32649523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biogenesis, functions and clinical significance of circRNAs in gastric cancer.
    Shan C; Zhang Y; Hao X; Gao J; Chen X; Wang K
    Mol Cancer; 2019 Sep; 18(1):136. PubMed ID: 31519189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.